This writer will be driven, a true self starter, who can track down and write up news, some features and lots of breaking stories, covering a host of major global companies that control a multibillion-dollar industry. Candidates will need to have a minimum of 2-3 years professional experience.
We’ve built a strong business around our two daily reports dedicated primarily to drug R&D, which we launched more than 5 years ago. In the past year we’ve added 4 weekly reports dedicated to niche biopharma areas like marketing, manufacturing and the FDA.
And now we’re adding a third, daily report in the mid-afternoon that will dig deep into the numbers, events and personalities of this fast-changing industry. We are completely independent.
You will be able to break stories that these companies won’t want to see, but will be expected to do it according to the highest professional standards of journalism. Controversy is by no means uncommon. This position involves some travel, perhaps internationally, lots of direct contact on Zoom or by phone, with a busy daily schedule to contend with.
The news flow here is a constant. You’ll be working with a tightly knit group of writers and editors — all working remotely from locations around the world — on a collaborative basis.
The daily schedule starts early, at 6:30 am ET, running through 3 pm ET. One other thing: For the right reporter, this is a lot of fun.
To apply, go here.
The Wall Street Journal is seeking a senior video journalist to join its Features video…
PCWorld executive editor Gordon Mah Ung, a tireless journalist we once described as a founding father…
CNBC senior vice president Dan Colarusso sent out the following on Monday: Before this year comes to…
Business Insider editor in chief Jamie Heller sent out the following on Monday: I'm excited to share…
Former CoinDesk editorial staffer Michael McSweeney writes about the recent happenings at the cryptocurrency news site, where…
Manas Pratap Singh, finance editor for LinkedIn News Europe, has left for a new opportunity…